Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers ...

br> <br> As a result, there are now two SCLC organizations active in Virginia. <br> <br> The SCLC, which has its national headquarters in Atlanta, was founded in 1957 after the Montgomery, Alabama, ...

Move aligns with UAE joining FX Global Code, with progress in Digital Dirham initiative UAE Central Bank unveils new symbol of Dirham WAM Abu Dhabi: The Central Bank of the UAE (CBUAE) unveiled a ...

The Central Bank of the UAE, on Thursday, unveiled the new symbol for the national currency in its physical and digital forms. The symbol was derived from the English name of the dirham to serve ...

The United Arab Emirates has officially approved a symbol to represent the Dirham currency unit. The Central Bank UAE has unveiled the physical form and the digital form of the new symbol. Previously, ...

Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai ...

The two lung cancer types are as follows: Non-Small Cell Lung Cancer [NSCLC] Small-Cell Lung Cancer [SCLC] Before diving into the ongoing phase 1 study itself, it is important to go over the fact ...

Preliminary results from the phase 1b/2 Olvi-Vec-SCLC-202 trial show that adding olvimulogene nanivacirepvec (olvi-vec; GL-ONC1), a modified oncolytic vaccinia virus, to platinum-based chemotherapy ...

In layperson’s terms, MRT-2359’s mechanism of action degrades the GSPT1 protein, which is a protein that certain cancers, such as CRPC, NSCLC, and SCLC, depend on to grow and survive.

Traveling to Montgomery in the early stages of the campaign, he counseled the young minister to initiate what would become the Southern Christian Leadership Conference (SCLC), using the bus ...

AstraZeneca’s IMFINZI TM (durvalumab) has received approval in the European Union as a monotherapy for treating adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...

Treatment with tarlatamab-dlle (Imdelltra) had a positive benefit-risk profile when used in previously treated patients with small cell lung cancer (SCLC), according to patient-reported outcomes (PROs ...